George Kassiotis

Omega Navigation Enterprises, Inc. operates as an investment holding company, which engages in the provision of marine transportation services through the ownership and operation of double hull product tankers. It focuses on seaborne transportation of refined petroleum products. The firm also provides technical, operating and administrative services to the joint venture companies. The company was founded on February 28, 2005 and is headquartered in Athens, Greece.

Ervaxx Ltd. is a British company that pioneers the use of dark antigens to deliver targeted immunotherapies for treating and preventing cancer. The company was founded in 2016 by George Kassiotis, Drew M. Pardoll and is based in London, UK. The company's powerful, proprietary edapt platform has been developed to discover and validate dark antigens providing an in-depth assessment of candidate antigens on primary tumor cells along with their immunogenic potential. Ervaxx is advancing a pipeline of T cell receptor-based therapies, off-the-shelf cancer vaccines, and other immunotherapies leveraging these insights into the role of dark antigens in cancer.